Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | 0.00% | 0.00% | -50.00% |
02-29 | Braxia Scientific Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
2023 | Braxia Scientific Corp. Announces Board Changes | CI |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +26.70% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
96.2
%
| 1 | 100.0 % | 2 | 96.2 % | +21.92% |
United States
3.8
%
| - | - | 0 | 3.8 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Roger McIntyre
CEO | Chief Executive Officer | - | 20-05-10 |
Peter Rizakos
DFI | Director of Finance/CFO | - | 21-01-07 |
Jason Wolkove
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-03 |
Joshua Rosenblat
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-27 |
Daniel Herrera
CTO | Chief Tech/Sci/R&D Officer | 47 | 22-07-03 |
Kevin Kratiuk
PRN | Corporate Officer/Principal | - | 18-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jerry Habuda
BRD | Director/Board Member | 67 | 19-08-18 |
Roger McIntyre
CEO | Chief Executive Officer | - | 20-05-10 |
Olga Cwiek
BRD | Director/Board Member | - | 21-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 263,708,939 | 149,209,994 ( 56.58 %) | 0 | 56.58 % |
Company contact information
Braxia Scientific Corp.
700 Bay Street Suite 1903
M5G 1Z6, Toronto
+604-408-7488
http://www.braxiascientific.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-50.00% | 1.04M | |
+18.41% | 83.07B | |
-29.08% | 70.89B | |
+3.59% | 28.32B | |
-7.08% | 17.73B | |
+2.07% | 17.43B | |
+0.93% | 15.64B | |
+6.78% | 13.46B | |
+8.40% | 12.82B | |
+68.45% | 12.69B |
- Stock Market
- Equities
- BRAX Stock
- Company Braxia Scientific Corp.